Arjun Agarwal
Senior Vice President, Finance at Oruka Therapeutics, Inc. (ORKA) since August 2024
Arjun Agarwal has filed 12 insider reports with the SEC since September 2024, as senior Vice President and finance at Oruka Therapeutics, Inc. (ORKA). In the last 12 months Arjun Agarwal sold $5.38M of stock on the open market. In the latest filing, on November 14, 2026, Arjun Agarwal sold 10,000 shares of Oruka Therapeutics, Inc. (ORKA) for $1.05M at an average of $104.97.
- Filings
- 12
- Companies
- 1
- Bought on market
- None
- Sold on market
- $5.38M
Companies where Arjun Agarwal is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Senior Vice President, Financesince August 2024 | 14,219 | $5.38M | $95.74 | Nov 14, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Nov 12, 2026-$1.05MORKASenior Vice President, Finance Agarwal Arjun exercised 10,000 shares at a strike of $15.69 and sold $1,049,658 worth of shares (10,000 units at $104.97) as part of a pre-agreed trading planForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Sep 21, 2026-$51KORKASenior Vice President, Finance Agarwal Arjun sold $51,035 worth of shares (533 units at $95.75) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 14,219 unitsForm 4Open-market sale10b5-1 plan
- Sep 15, 2026-$926KORKASenior Vice President, Finance Agarwal Arjun sold $926,010 worth of shares (10,019 units at $92.43) as part of a pre-agreed trading plan and exercised 9,459 shares at a strike of $15.88, decreasing direct ownership by 4% to 14,752 units (for tax liability)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Aug 13, 2026-$1.07MORKASenior Vice President, Finance Agarwal Arjun exercised 10,000 shares at a strike of $15.69 and sold $1,066,572 worth of shares (10,000 units at $106.66) as part of a pre-agreed trading planForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jul 13, 2026-$846KORKASenior Vice President, Finance Agarwal Arjun exercised 9,999 shares at a strike of $15.69 and sold $846,180 worth of shares (9,999 units at $84.63) as part of a pre-agreed trading planForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jun 22, 2026-$128KORKASenior Vice President, Finance Agarwal Arjun sold $128,468 worth of shares (1,587 units at $80.95) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 15,312 unitsForm 4Open-market sale10b5-1 plan
- Jun 15, 2026-$687KORKASenior Vice President, Finance Agarwal Arjun exercised 9,459 shares at a strike of $15.88 and sold $687,035 worth of shares (9,854 units at $69.72) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 16,899 units to cover taxesForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- May 18, 2026-$608KORKASenior Vice President, Finance Agarwal Arjun exercised 7,833 shares at a strike of $28.80 and sold $607,806 worth of shares (10,290 units at $59.07) as part of a pre-agreed trading plan, decreasing direct ownership by 13% to 16,406 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Mar 16, 2026-$16.3KORKASenior Vice President, Finance Agarwal Arjun sold $16,313 worth of shares (395 units at $41.30), decreasing direct ownership by 2% to 18,863 unitsForm 4Open-market sale
- Jan 23, 2026ORKASVP, Finance Agarwal Arjun was granted 17,500 shares, increasing direct ownership by 995% to 19,258 unitsForm 4Grant or award
- Jan 22, 2025ORKASEC Form 4 filed by SVP, Finance Agarwal ArjunForm 4Grant or award
- Aug 29, 2024ORKAArjun Agarwal became an insiderForm 3New insider
Compare Arjun Agarwal with
- Arjun Agarwal vs Joana Goncalves1 shared
- Arjun Agarwal vs Kristine M Ball1 shared
- Arjun Agarwal vs Lawrence Otto Klein1 shared
- Arjun Agarwal vs Paul T Quinlan1 shared
- Arjun Agarwal vs Laura Lee Sandler1 shared
- Arjun Agarwal vs Larry Todd Edwards1 shared
Other insiders at the same companies
- Joana GoncalvesORKA
- Kristine M BallORKA
- Lawrence Otto KleinORKA
- Paul T QuinlanORKA
- Laura Lee SandlerORKA
- Larry Todd EdwardsORKA
- Fairmount Funds Management LLCORKA
- Carl DambkowskiORKA
- Samarth KulkarniORKA
- Christopher Nathan MartinORKA
- Cameron TurtleORKA
- Venrock Healthcare Capital Partners III, L.P.ORKA
Questions about Arjun Agarwal
- What is Arjun Agarwal's role at Oruka Therapeutics, Inc.?
- Arjun Agarwal reports to the SEC as senior Vice President and finance at Oruka Therapeutics, Inc. (ORKA), according to the latest filing on November 14, 2026.
- How many shares does Arjun Agarwal own?
- After the latest filing that states it, Arjun Agarwal directly owned 14,219 shares of Oruka Therapeutics, Inc. (ORKA). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Arjun Agarwal bought or sold stock recently?
- The most recent open-market sale was on November 12, 2026: sold 10,000 shares of Oruka Therapeutics, Inc. (ORKA) for $1.05M at an average of $104.97.
- How do I get alerts when Arjun Agarwal files?
- Follow Arjun Agarwal on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Arjun Agarwal filed 3 times in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Arjun Agarwal (SEC CIK 0002033974). Totals count each trade once, skipping amendments whose original is on file, from Sep 6, 2024 on. View on SEC EDGAR